Genenta Science SpA Sponsored ADR (GNTA) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Genenta Science’s proposed loyalty share program presents a considerable risk by potentially reducing the liquidity of its American Depositary Shares (ADSs). This program may concentrate voting power among a small group of long-term, registered shareholders, thereby diluting the influence of ADS holders on corporate decisions. Such concentration of power could deter investors seeking control or aiming to instigate changes in management or company strategy. Moreover, the program’s structure could discourage takeover bids, possibly affecting the market value of Genenta Science’s ADSs unfavorably.
Overall, Wall Street has a Moderate Buy consensus rating on GNTA stock based on 2 Buys.
To learn more about Genenta Science SpA Sponsored ADR’s risk factors, click here.